Technology update: SARS-CoV-2 research

Since January 2020, IDT has offered oligos and probes for the detection of SARS-CoV-2 using third party qPCR protocols, in both stocked and custom formats. We also offer custom guide RNAs for CRISPR-Cas13 research, and our NGS line-up is a great way to start exploring evolutionary questions related to the COVID-19 pandemic.

Learn more about traditional and emerging workflows in COVID-19 research, and where our qPCR, CRISPR, and NGS products fit in.

Published on: May 13, 2020